Whether opioids affect tumor growth has been an important but unanswered question in tumor biology for decades. While opioids are widely used to treat pain in cancer patients, our preliminary data show that morphine and other opioids in clinically relevant doses can promote angiogenesis to enhance breast tumor growth and metastases in mice by stimulating pro-angiogenic and survival promoting signaling. Conversely, the opioid receptor antagonist naloxone inhibits tumor growth, further corroborating that opioid receptors play a critical role in tumor growth. We hypothesize that (a) specific opioid receptors regulate tumor angiogenesis through distinct intracellular signaling pathways, and (b) endogenous and clinically relevant levels of opioids promote tumor angiogenesis and growth, and naloxone inhibits this process. We will test these hypothesis with:
Aim#1. Test that tumor growth, tumor angiogenesis, metastasis and survival are: [a] promoted by opioids in a dose and time dependent fashion [b] prevented and/or inhibited by naloxone in a dose and time dependent manner [c] modulated by endogenous opioids.
Aim#2. Identify the specific opioid receptor(s) involved in the modulation of tumor angiogenesis, tumor growth and metastases using [a] receptor specific agonists and antagonists and [b] opioid receptor knockout mice.
Aim#3. Examine if opioids modulate blood flow and vascular permeability in tumors.
Aim#4. Identify signaling mechanism(s) induced by specific opioid receptors and their inhibition to prevent tumor growth.
Aim#5. Prevent/delay tumor growth by naloxone and its more potent bivalent derivatives. Human and mouse breast tumor models including C3-TAG transgenic, MCF7, SCK, T241 fibrosarcoma (non-breast) in nude or immunocompetent A/J or C57 background wild type mice will be used for extensive in vivo experiments. Human dermal microvascular endothelial cells, SCK and C3-TAG tumor cells and human embryonic kidney cells transfected with different opioid receptors will be used for in vitro studies. If our hypothesis are true, this Proposal may lead to the development of novel therapeutics for breast cancer treatment and to altered clinical decision making in treating pain in cancer patients.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA109582-02
Application #
7047942
Study Section
Special Emphasis Panel (ZRG1-DT (01))
Program Officer
Forry, Suzanne L
Project Start
2005-04-01
Project End
2010-02-28
Budget Start
2006-04-01
Budget End
2007-02-28
Support Year
2
Fiscal Year
2006
Total Cost
$224,931
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Nguyen, J; Luk, K; Vang, D et al. (2014) Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer. Br J Anaesth 113 Suppl 1:i4-13
Zylla, Dylan; Gourley, Brett L; Vang, Derek et al. (2013) Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer. Cancer 119:4103-10
Mitra, Ranjana; Guo, Zhijun; Milani, Monica et al. (2011) CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET). J Biol Chem 286:17543-59
Fujioka, Naomi; Nguyen, Julia; Chen, Chunsheng et al. (2011) Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer. Anesth Analg 113:1353-64
Bodempudi, V; Ohlfest, J R; Terai, K et al. (2010) Blood outgrowth endothelial cell-based systemic delivery of antiangiogenic gene therapy for solid tumors. Cancer Gene Ther 17:855-63
Elikkottil, Jaseena; Elikottil, Jaseena; Gupta, Pankaj et al. (2009) The analgesic potential of cannabinoids. J Opioid Manag 5:341-57
Luikart, Sharon D; Panoskaltsis-Mortari, Angela; Hinkel, Timothy et al. (2009) Mactinin, a fragment of cytoskeletal alpha-actinin, is a novel inducer of heat shock protein (Hsp)-90 mediated monocyte activation. BMC Cell Biol 10:60
Xu, J; Liu, X; Jiang, Y et al. (2008) MAPK/ERK signalling mediates VEGF-induced bone marrow stem cell differentiation into endothelial cell. J Cell Mol Med 12:2395-406
Weber, Marc L; Farooqui, Mariya; Nguyen, Julia et al. (2008) Morphine induces mesangial cell proliferation and glomerulopathy via kappa-opioid receptors. Am J Physiol Renal Physiol 294:F1388-97
Farooqui, M; Li, Y; Rogers, T et al. (2007) COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Br J Cancer 97:1523-31

Showing the most recent 10 out of 13 publications